Glycopyrronium topical wipes (1:30), urinary incontinence (4:20), augmentation for treatment-resistant depression (13:20), pelvic inflammatory disease (14:20), dual antiplatelet therapy for transient ischemic attack and minor stroke (19:50), ruling out community-acquired pneumonia (23:00).